Wealthfront Advisers
EW icon

Wealthfront Advisers’s Edwards Lifesciences EW Stock Holding History

Quarter Market Value Status Shares Shares
Change %
Trade Value Portfolio Weight Portfolio Position
2025
Q2
$2.16M Buy
27,579
+2,566
+10% +$201K 0.01% 558
2025
Q1
$1.81M Buy
25,013
+3,065
+14% +$222K ﹤0.01% 559
2024
Q4
$1.62M Buy
21,948
+5,846
+36% +$433K ﹤0.01% 567
2024
Q3
$1.06M Sell
16,102
-19,359
-55% -$1.28M ﹤0.01% 633
2024
Q2
$3.28M Buy
35,461
+1
+0% +$92 0.01% 364
2024
Q1
$3.39M Buy
35,460
+321
+0.9% +$30.7K 0.01% 364
2023
Q4
$2.68M Sell
35,139
-20,353
-37% -$1.55M 0.01% 395
2023
Q3
$3.84M Buy
55,492
+18,145
+49% +$1.26M 0.02% 267
2023
Q2
$3.52M Buy
37,347
+1,580
+4% +$149K 0.01% 290
2023
Q1
$2.96M Buy
35,767
+3,075
+9% +$254K 0.01% 324
2022
Q4
$2.44M Sell
32,692
-4,253
-12% -$317K 0.01% 353
2022
Q3
$3.05M Buy
36,945
+1,482
+4% +$122K 0.02% 275
2022
Q2
$3.37M Sell
35,463
-1,232
-3% -$117K 0.02% 258
2022
Q1
$4.32M Buy
36,695
+6,413
+21% +$755K 0.02% 230
2021
Q4
$3.92M Buy
30,282
+4,004
+15% +$519K 0.02% 235
2021
Q3
$2.98M Buy
26,278
+3,956
+18% +$448K 0.01% 255
2021
Q2
$2.31M Buy
22,322
+2,452
+12% +$254K 0.01% 275
2021
Q1
$1.66M Buy
19,870
+148
+0.8% +$12.4K 0.01% 306
2020
Q4
$1.8M Sell
19,722
-482
-2% -$44K 0.01% 249
2020
Q3
$1.61M Sell
20,204
-361
-2% -$28.8K 0.01% 226
2020
Q2
$1.42M Buy
20,565
+13,551
+193% +$936K 0.01% 241
2020
Q1
$1.32M Sell
7,014
-2,525
-26% -$476K 0.01% 209
2019
Q4
$2.23M Buy
9,539
+438
+5% +$102K 0.02% 158
2019
Q3
$2M Buy
9,101
+506
+6% +$111K 0.02% 170
2019
Q2
$1.59M Sell
8,595
-228
-3% -$42.1K 0.01% 187
2019
Q1
$1.69M Buy
8,823
+2,248
+34% +$430K 0.02% 176
2018
Q4
$1.01M Buy
+6,575
New +$1.01M 0.01% 245